



-
- Systems
Cyto-Facto Inc.: Advancing cell & gene therapies, providing the promise of health
In April 2023, Cyto-Facto Inc. (CF), a spin-off of the Foundation for Biomedical Research and Innovation at Kobe, Japan, began manufacturing gene and cell preparations to meet a worldwide growing need for new treatments that leverage a patient’s immune system to fight disease. One example is an em…